Akcea Therapeutics, Inc. (AKCA): Price and Financial Metrics

Akcea Therapeutics, Inc. (AKCA)

Today's Latest Price: $19.08 USD

0.32 (1.71%)

Updated Nov 19 4:00pm

Add AKCA to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 328 in Biotech

See all "A" rated Strong Buy stocks

AKCA Stock Summary

  • Akcea Therapeutics Inc's stock had its IPO on July 14, 2017, making it an older stock than just 6.5% of US equities in our set.
  • The ratio of debt to operating expenses for Akcea Therapeutics Inc is higher than it is for about only 11.32% of US stocks.
  • Revenue growth over the past 12 months for Akcea Therapeutics Inc comes in at 228.6%, a number that bests 97.38% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to AKCA, based on their financial statements, market capitalization, and price volatility, are HRTX, PBYI, BLDP, PTCT, and QUIK.
  • Visit AKCA's SEC page to see the company's official filings. To visit the company's web site, go to www.akceatx.com.
AKCA Daily Price Range
AKCA 52-Week Price Range

AKCA Stock Price Chart More Charts

AKCA Price/Volume Stats

Current price $19.08
Prev. close $18.76
Day low $18.66
Day high $19.34
50-day MA $18.86
200-day MA $23.28
52-week high $35.82
52-week low $13.90
Volume 149,219
Avg. volume 231,582
Dividend yield N/A
Market Cap 1.79B

Akcea Therapeutics, Inc. (AKCA) Company Bio

Akcea Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing drugs to treat patients with cardiometabolic diseases caused by lipid disorders in the United States and internationally. The company was founded in 2014 and is based in Cambridge, Massachusetts.

AKCA Latest News Stream

Event/Time News Detail
Loading, please wait...

AKCA Latest Social Stream

Loading social stream, please wait...

View Full AKCA Social Stream

AKCA Price Returns

1-mo 5.53%
3-mo -13.51%
6-mo -10.72%
1-year -35.67%
3-year N/A
5-year N/A
YTD -36.70%
2018 73.62%
2017 N/A
2016 N/A
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.4643 seconds.